Showing results 13 to 17 of 17
< previous
Issue Date | Title | Author(s) |
2020-11-03 | MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose. | Booth, J; Caillet, V; Briggs, A; Hardcastle, N; Angelis, G; Jayamanne, D; Shepherd, M; Podreka, A; Szymura, K; Nguyen, DT; Poulsen, P; O'Brien, R; Harris, B; Haddad, C; Eade, T; Keall, P |
2016-09-01 | Oxidative stress in prostate cancer patients: A systematic review of case control studies | Oh, B; Figtree, G; Costa, D; Eade, T; Hruby, G; Lim, S; Elfiky, A; Martine, N; Rosenthal, D; Clarke, S; Back, M |
2016-03-04 | A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II) | Siva, S; Kron, T; Bressel, M; Haas, M; Mai, T; Vinod, S; Sasso, G; Wong, W; Le, H; Eade, T; Hardcastle, N; Chesson, B; Pham, D; Høyer, M; Montgomery, R; Ball, D |
2020-07 | Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial. | Keall, P; Nguyen, DT; O'Brien, R; Hewson, E; Ball, H; Poulsen, P; Booth, J; Greer, P; Hunter, P; Wilton, L; Bromley, R; Kipritidis, J; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, A; Turner, S; Arumugam, S; Sidhom, M; Hardcastle, N; Siva, S; Tai, K-H; Gebski, V; Martin, J |
2021-08-29 | Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) | Siva, S; Bressel, M; Mai, T; Le, H; Vinod, S; de Silva, H; Macdonald, S; Skala, M; Hardcastle, N; Rezo, A; Pryor, D; Gill, S; Higgs, B; Wagenfuehr, K; Montgomery, R; Awad, R; Chesson, B; Eade, T; Wong, W; Sasso, G; De Abreu Lourenco, R; Kron, T; Ball, D; Neeson, P; Bettington, C; Cook, O; Foote, M; Gowda, R; Haas, M; Haynes, NM; Hilder, B; Lao, L; Lim, A; Ludbrook, J; Jansen, T; MacManus, M; McCullough, SA; Moore, A; Ritchie, D; Shaw, M; Sia, J; Syed, F; Tang, C; Trapani, J |